Physician profile
Gemma Kim
NPI 1376554956
$14,915.62
in general payments reported to CMS, 2019-2025
10 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.50 · 2020: $1,403 · 2021: $1,386 · 2022: $1,552 · 2023: $1,495 · 2024: $8,927 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,250 · Consulting Fee: $3,750 · Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,250.00 |
| Consulting Fee | $3,750.00 |
| Food and Beverage | $557.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $9,083.56 | 2021-2024 | Nexplanon |
| Abbvie INC. | $3,750.00 | 2024 | |
| Merck Sharp & Dohme LLC | $1,405.28 | 2019-2020 | |
| Abbott Laboratories | $147.52 | 2024 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $135.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $124.77 | 2022 | |
| Neurelis, INC. | $119.72 | 2023 | Valtoco |
| Lexicon Pharmaceuticals, INC. | $115.83 | 2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.31 | 2022-2024 | Lifevest |
| Allergan, INC. | $14.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gemma Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.